17.01BMarket Cap-22314P/E (TTM)
9.73High9.61Low2.66KlotVolume9.72Open9.62Pre Close2.56MTurnover0.10%Turnover RatioLossP/E (Static)1.76BShares12.0252wk High2.42P/B2.49BFloat Cap7.2852wk Low11.54Limit Up258.34MShs Float16.99Historical High7.70Limit Down1.25%Amplitude7.28Historical Low--Dividend TTM9.63Avg Price1.93KlotAsk--Div YieldTTM100Lot Size693.13lotBid
InnoCare Pharma Stock Forum
This is a multicente...
In the...
Financial Highlights
• Revenue increased by 18.1% to RMB738.5 million in 2023, including RMB670.7 million from orelabrutinib, an increase of 18.5%, mainly due to the continuous and rapid ramp-up of orelabrutinib sales.
• Gross ...
No comment yet